Cipla | CIPLA - Cost Of Sales

Stock Price
1,346.00
Daily Change
-12.10 -0.89%
Monthly
1.32%
Yearly
-4.37%
Q1 Forecast
1,315.62

Cipla reported INR29.1B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
aTyr Pharma USD 22.13M 6.75M Sep/2025
Cara Therapeutics USD 0 0 Mar/2025
Cipla INR 29.1B 1.16B Dec/2025
Dr.Reddys Laboratories INR 36.16B 3.75B Dec/2025
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
Infinity Pharmaceuticals USD 352K 89K Jun/2023
Minerva Neurosciences 386K 31K Jun/2024
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Sangamo BioSciences 2.42M 1.11M Jun/2024
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
TherapeuticsMD USD -11.99M 12.34M Dec/2022
UPL INR 66.73B 1.49B Dec/2025